Yan Yang

机构：Hubei University of Medicine, Central South University, Chongqing University, Beijing University of Chinese Medicine, Zunyi Medical University, Anhui Medical University, Sichuan University, Renji Hospital, National Clinical Research Center for Digestive Diseases, West China Hospital of Sichuan University, First People's Hospital of Yunnan Province, Hubei Provincial Center for Disease Control and Prevention, Gansu Provincial Hospital, Xiangtan Electric Manufacturing Group (China), Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, National Clinical Research, Henan Provincial People's Hospital, Tang Du Hospital, Third Xiangya Hospital, First Affiliated Hospital of Hebei Medical University, Tongji Hospital, Affiliated Hospital of Zunyi Medical College, Huazhong University of Science and Technology, Southwest Jiaotong University, Chengdu University of Traditional Chinese Medicine, Chongqing Medical University, Air Force Medical University · ORCID：0000-0001-8146-8040

发表论文 282 篇 · 总被引 6070 次 · h-index 40

代表论文

Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial (2026 · BMJ · 被引 4)
Semaglutide-associated NAION: a proposed ‘two-hit’ model involving buried optic disc drusen and sustained hypohydration (2026 · British Journal of Ophthalmology · 被引 1)
Association and predictive value of sarcopenic obesity for the prognosis of lung cancer patients receiving immune checkpoint inhibitors (2026 · Frontiers in Nutrition · 被引 1)
P3.13.09 Surface Targeting Strategies to Overcome Heterogeneity Associated With Treatment Resistance in Small Cell Lung Cancer (SCLC) (2025 · Journal of Thoracic Oncology · 被引 1)
Association between sarcopenia and falls, fractures, hospital readmission, and all-cause mortality in older adults with endocrine disorders: a longitudinal study of aging in China (2025 · BMC Musculoskeletal Disorders · 被引 1)
Associations and potential utility of composite obesity and metabolic indices for osteoporosis risk assessment in Chinese adult men: a cross-sectional study (2026 · BMC Musculoskeletal Disorders)